LTR Secures Indian Patent Supporting SPONTAN and ROXUS

Summary by 6ix AI

LTR Pharma Limited has secured an Indian patent for its formulations and methods related to treating erectile dysfunction, specifically for its intranasal technology supporting SPONTAN and ROXUS products. The patent, granted by the Indian Patent Office, protects specific formulation characteristics and extends protection until a future date, subject to maintenance requirements. This milestone is part of LTR Pharma's strategy to strengthen its international intellectual property portfolio as it advances clinical development and commercialization efforts.

Written by 6ix AI from the company’s filing. How 6ix writes summaries